go-v.orgcodex
Menu
Page tools

codex · Chemistry

Elacestrant

Diagram for Elacestrant
Elacestrant, sold under the brand name Orserdu, is a selective estrogen receptor degrader (SERD) used in the treatment of breast cancer. It is taken by mouth. · image: Wikimedia Commons

Elacestrant, sold under the brand name Orserdu, is a selective estrogen receptor degrader (SERD) used in the treatment of breast cancer. It is taken by mouth. Elacestrant is an antiestrogen that acts as an antagonist of estrogen receptors, which are the biological targets of endogenous estrogens like estradiol. The most common side effects of elacestrant include body pain, nausea and vomiting, increased serum lipids, elevated liver enzymes, fatigue, decreased hemoglobin, raised creatinine, decreased appetite, diarrhea, headache, constipation, abdominal pain, and hot flashes.

Elacestrant was approved for medical use in the United States in January 2023, and in the European Union in September 2023.

Wikipedia contributors, "Elacestrant", Wikipedia, revision 1329034709, retrieved 20 November 2026, source, CC BY-SA 4.0.

More Chemistry · Search the codex